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Views and reviews
Pituitary tumor aPoPlexy
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abstract – Pituitary tumor apoplexy is a medical emergency due to acute infarction or hemorrhage in the 
pituitary gland. In this review, the authors discuss the sellar anatomy, the pituitary gland and adenomas’ 
vascularization and the general aspects of the syndrome such as its ethiopatogenesis, predisposing factors, 
clinical features, treatment and prognosis.
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apoplexia em tumor hipofisário
resumo – A apoplexia em tumor hipofisário é uma emergência médica decorrente do infarto agudo 
ou hemorrágico na glândula hipófise. Nesta revisão os autores discutem a anatomia da região selar, a 
vascularização da hipófise e adenomas hipofisários, e demais aspectos da síndrome como etiopatogenia, 
fatores predisponentes, quadro clínico, tratamento e prognóstico.
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Pituitary apoplexy is a potentially life-threatening disor-
der due to acute ischemic infarction or hemorrhage of the 
pituitary gland. The main clinical features of this syndrome 
are headache, nausea, vomiting, visual impairment, altered 
mental status, and even coma1-4. As the primary event in-
volves the adenoma, the syndrome should be referred to 
as pituitary tumor apoplexy and not as pituitary apoplexy5. 
Notwithstanding pituitary apoplexy occurs within pituitary 
adenomas, it may also occur in non-adenomatous or even 
the normal pituitary gland6, especially during pregnancy.
Although the “subclinical pituitary apoplexy”7-9 ter-
minology is widely used to describe anatomophatologi-
cal evidence of asymptomatic pituitary ischemia or hem-
orrhage, it is meaningful to note that pituitary apoplexy 
is a clinical syndrome rather than an anatomopathologi-
cal definition10,11. 
anatomy of the sellar region
The pituitary gland is circumscribed by the sphenoid 
bone among its whole surface and enclosed with the dia-
phragma sellae. It relies on the sella turcica under the hy-
pothalamus and optic chiasma. In the adult, it measures 
approximately 12×9×6mm diameters and weights 0,6g, 
and during pregnancy its volume may double. The pitu-
itary gland can be divided into two major parts: one sit-
uated at the anterior site corresponding to 80% of the 
gland (adeno-pituitary) and the remaining 20% on the 
posterior site of the gland (neuro-pituitary)12.
Vascularization of hyPothalamus 
and Pituitary gland
There are up to ten portal pituitary vessels that orig-
inate dorsally at capillaries from the median eminence. 
These vessels move alongside the ventral surface of the 
anterior pituitary stalk and drain to the adeno-pituitary 
making anastomosis with the neuro-pituitary capillaries. 
The circulation is predominantly through hypothalamus 
to pituitary gland and allows pituitary to be the most ir-
rigated region of the body (0.8 ml/g/min). It is still not 
known whether the anterior lobe of the pituitary gland 
receives its blood supply exclusively from the portal cir-
culation or if there is some additional arterial blood sup-
ply5. It is believed that 70 to 90% of adeno-pituitary irri-
gation comes from major portal vessels and the remaining 
from lesser ones. Another controversial issue is the pen-
etration of loral artery to the anterior lobe passing away 
the infundibular stem, and providing arterial blood to pi-
tuitary cells. A further potential source of direct arteri-
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al supply for the adeno-pituitary could be capsular arter-
ies, originated from inferior pituitary arteries which are 
branches from the internal carotid artery. on the other 
side, venous drainage takes place within adjacent venous 
sinus to the jugular veins12. 
To sum up, pituitary gland is one of the greatest irri-
gated structures of our organism with a complex vascu-
lar system13, and therefore pituitary adenomas have a 5.4 
greater chance to bleed than any other brain tumor14.
Vascularization of Pituitary adenomas
The number and size of tumoral vessels are variable. 
Generally they are lesser than the normal pituitary vessels 
and are divided into irregular islets. Under electronic mi-
croscopy they have incomplete maturation, low fenestra-
tion, and fragmented basal membranes with sized perivas-
cular spaces filled with plasmatic proteins or red cells15,16. 
Adenomas receive a mixed arterial or portal blood, but in 
contrast to the normal pituitary gland, the arterial source 
is generally more dominant in pituitary adenomas17.
The angiographic characteristic of tumoral vessels that 
supply adenomas implies that they come from the inferi-
or pituitary artery, and are under the influence of system-
ic arterial pressure12,17. 
etioPathology
The etiopathology of pituitary apoplexy is still a mat-
ter of debate. some authors believe pituitary apoplexy 
occurs due to rapid tumoral growth that outstrips arte-
rial supply18-20. It is uncertain whether the pathological 
process is a primary hemorrhage or whether the event is 
really a hemorrhagic infarction. The size of the adenoma 
appears to be a major factor21, but it is known that even 
smaller adenomas can bleed. Another rationale for pitu-
itary apoplexy could be the tumoral tissue growing inside 
the narrow space situated between the pituitary stalk and 
diaphragma sellae leading to constriction of the thin vas-
cular net adjacent to the stalk, and finally ischemia, ne-
crosis and hemorrhage on the anterior lobe and tumor-
al tissue22. Taking into account that the adenoma is sup-
plied by the inferior pituitary artery, the compression of 
the superior pituitary artery and its branches against the 
diaphragma sellae could lead to ischemia of the adeno-
pituitary and not the adenoma. If this is true the hemor-
rhage would begin within the normal pituitary gland in-
stead of the adenoma itself22. 
The intentional (surgical) occlusion in animals or hu-
mans of portal pituitary vessels leads to ischemic infarc-
tion and not hemorrhage. The process begins with the vol-
ume reduction of acinar cells and its splitting from the 
basal membranes, culminating to necrosis23. Patients who 
have tumor infarction have generally less severe clinical 
symptoms and longer course before presenting for medi-
cal care than those who have hemorrhage or hemorrhag-
ic infarction of the adenoma24. 
The hypothesis of tumoral “intrinsic” factors ending to 
hemorrhage is also suggested. There is a statistically sig-
nificant relationship between the aggressive and invasive 
tumoral behavior and hemorrhage11,23. The role of vasos-
pasm was also implicated on the etiophatology of pitu-
itary infarction. Intracranial aneurisms are more often as-
sociated to pituitary adenomas than in the general pop-
ulation or with other brain tumors5,12. Additionally, pitu-
itary adenomas bleed much more than any other central 
nervous system tumor. Thus, one might speculate of an 
“intrinsic” factor such as a kind of tumoral-vasculopathy 
underlying the mechanism of aneurism development and 
pituitary hemorrhage25. 
PredisPosing factors 
Numerous conditions have been linked to pituitary 
apoplexy but in the majority of cases it happens with-
out any predisposing factor but pituitary adenoma5,25. 
The main predisposing factors associated to pituitary ap-
oplexy (~25% of cases) are: medication (bromocriptine 
and cabergoline)26-28, radiotherapy29, pituitary function 
tests30,31, diabetes mellitus, trauma, thrombocytopenia or 
recent surgery32-36. high blood pressure is also considered 
as a risk factor for pituitary apoplexy although this asso-
ciation is not always seen1,6. 
The prevalence of apoplexy according to different 
subtypes of pituitary tumors is homogeneous with a small 
trend for non-functioning adenomas and prolactinomas 
to develop apoplexy. Gh–, AcTh–, Tsh–, and gonado-
trophin-secreting tumors shares similar prevalence5,21. It 
is believed that between non-functioning adenomas and 
prolactinomas the prevalence is slightly greater in the for-
mer, perhaps because the peak prevalence of pituitary 
apoplexy is similar to that of non-functioning adenomas, 
which is the fiftieth decade of life12. 
clinical features
The diagnosis of pituitary tumor apoplexy is frequent-
ly missed because, in addition to its relative rarity, the ex-
istence of an adenoma is not often suspect at the time 
time of ictus. headache is the major symptom of pitu-
itary apoplexy in patients without altered mental sta-
tus, and it can have sudden onset with severe pain. occa-
sionally it is generalized, but most often retro-orbitary or 
peri-orbitary. headache is not necessarily associated with 
sub-arachnoid hemorrhage or means tumoral growth be-
yond the sella turcica. The potential mechanisms under-
lying headache in pituitary apoplexy are meningeal irri-
tation, dura-mater compression, enlargement of sella tur-
cica walls, or involvement of the superior division of the 
trigeminal nerve inside cavernous sinus37. 
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Altered visual field or visual acuity means involvement 
of the optic nerves, chiasma, or optic tracts. Motor ocular 
nerves (III, Iv, and vI) are vulnerable at the cavernous si-
nus and therefore in the majority of patients that do not 
show altered mental status headache is associated with 
diplopia5,12. The medial aspect of the cavernous sinus cor-
responds to the lateral aspect of the pituitary fossa and 
for that reason an acute hemorrhage or necrosis within 
this region can shift the oculomotor nerves. Thus, visual 
impairment and the presence of motor ocular involvement 
do not necessarily means supra or para-sellar growth of 
pituitary tumors. Ipsilateral mydriasis and ptosis are owing 
to IIIrd nerve involvement. Facial numbness may also take 
place due to the vth nerve first division involvement12. 
Altered mental status is the most severe neurological 
finding in patients with pituitary apoplexy5. Its mechanism 
remains elusive and might be related to sub-arachnoid hem-
orrhage, increased intracranial pressure, obstructive hydro-
cephalus, adrenal insufficiency leading to arterial hypoten-
sion and hypoglycemia, and hypothalamic compression. 
Nausea and vomiting may occur due to adrenal in-
sufficiency, meningeal irritation, and hypothalamic dys-
function or raised intracranial pressure. Neck stiffness is 
observed in patients with pituitary apoplexy and should 
raise the attention for sub-arachnoid hemorrhage3. 
Focal signs such as loss of muscle strength or aphasia 
are less common and are attributed to internal carotid ar-
tery compression or vasospasm6. 
The majority of patients do not have the diagnosis of 
pituitary adenoma at the time of pituitary apoplexy, but a 
retrospective and careful evaluation of these patients can 
show previous evidence of endocrine dysfunction. The 
most clinically important deficit is that of AcTh because 
it leads to acute glucocorticoid insufficiency occurring at 
the time of severe physical stress. The majority of patients 
present with, at least, partial hypopituitarism. reviewing 
a series of patients that had pituitary apoplexy, veldhuis 
and hammond38 found multiple adeno-pituitary hormon-
al deficiencies such as: Gh deficit (88%), AcTh hyposecre-
tion (66%), hypothyroidism (42%) and hypogonadothrofic 
hypogonadism (85%). 
Transient diabetes insipidus is not a common feature 
of pituitary apoplexy and is reported in only 4% of cases39. 
rarely, inappropriate Adh secretion occurs, perhaps due 
to sparing of neuro-pituitary or pituitary stalk10. 
neuroimaging
Although it is in disuse, plain radiography of the skull 
is a quick and inexpensive method for evaluating pituitary 
apoplexy showing enlargement of the pituitary fossa and 
destruction of sellar dorsum4. rarely, a fracture of sellar 
dorsum is seen, and this is considered an specific sign of 
pituitary apoplexy. A normal plain radiography does not 
exclude pituitary apoplexy. 
A recent hemorrhage can appear as a single or mul-
tiple lesion with hyperdense sign on brain comput-
er tomography (cT) (Fig 1) and no one or tiny contrast 
enhancemet4,12,40. on subsequent days after hemorrhage 
a progressive reduction of lesion hyperdensity occurs and 
after iodine contrast injection a peripheral ring is seen 
around the lesion22. At this time (approximately four days 
after bleeding) the hemorrhage can be misinterpreted as 
cystic degeneration, abscess, or local infarction, since all 
these conditions have lower density sign on scans25. Brain 
cT can also demonstrate sub-arachnoid hemorrhage and 
whether there is involvement of brain and ventricles. 
sometimes the differentiation between a non-complicat-
ed and a bleeding adenoma can be difficult or even impos-
sible because the observed densities on cT may be variable 
and there is no hallmark to differentiate both conditions. 
occasionally, serial scans are recommended but it should 
Fig 1. Note on this sellar computer tomography (coronal view) the ad-
enoma located at the sella turcica with an acute hemorrhage seen 
as an hyperdense lesion.
Fig 2. Note on this T1-weighted magnetic resonance imaging (coro-
nal view) a sellar and suprasellar mass (adenoma) with a hyperin-
tense chronic hemorrhage.
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be taken into consideration that the first three days after 
pituitary apoplexy are the best period for cT handling34. 
Unless specific techniques of imaging acquisition are 
obtained (diffusion-weighted)4 brain magnetic resonance 
imaging (MrI) is less efficient than cT in the acute stage of 
pituitary apoplexy. on the sub-acute and chronic stages of 
pituitary apoplexy brain MrI is considerably better than 
cT25. one of the advantages of MrI is the possibility of es-
timating the onset of bleeding. In the acute stage of pitu-
itary apoplexy (first seven days) it is seen on MrI charac-
teristic hypo- or isointense lesions on T1- and T2-weigthed 
images; between seven to fourteen days on the sub-acute 
stage there is marginal signal reinforcement although the 
hematoma core remains isointense; on the chronic stage 
there is an overall increase on T1- and T2- signal (Fig 2). The 
hyperintense lesion on MrI may last much longer than cT 
(up to one year after pituitary apoplexy)12. 
hypersignal on T1-weighted sequences is seen on hem-
orrhagic tissues, fat, and lesions with high protein or mel-
anin content. Thus, intra-sellar tumors that may present 
with T1 hyperintense signal are craniopharingiomas, lipo-
mas, dermoid cysts, metastatic melanomas or any oth-
er hemorrhagic tumor34. clinical characteristics together 
with other brain MrI abnormalities may help to elucidate 
diagnosis. Unlike pituitary apoplexy on T2-weighted imag-
es sub-acute or chronic hemorrhagic tissues, lipomas, der-
moid cysts, and melanomas are often hypointense. cran-
iopharingiomas may be hyperintense either on T1 or T2 im-
ages due to its high protein content within cysts, becom-
ing a difficult differential diagnosis with pituitary tumors 
that bleed or show necrosis12. craniopharingiomas, lipom-
as, and dermoid cysts generally presents with slow clini-
cal deficits opposing to hemorrhagic or metastatic lesions 
that presents with acute neurological manifestations. 
Angiography may also be helpful in the management 
of pituitary apoplexy as it shows the presence or absence 
of concomitant aneurism (7% of cases), and vasospasm. If 
there are no associated abnormalities the tumoral mass 
can be seen with contrast enhancement. Angiography is 
obligatory especially in patients with neck stiffness ac-
companied to focal neurological signs or inconclusive cT 
or MrI scans4. 
differential diagnosis 
clinical conditions frequently misdiagnosed as pitu-
itary apoplexy are sub-arachnoid hemorrhage due to rup-
tured intracranial aneurism and meningitis. other diseases 
that may share similar clinical characteristics are basilar ar-
tery occlusion, hypertensive encephalopathy, brain abscess 
or cyst, cavernous sinus thrombosis, intracerebral hemato-
ma, encephalitis, retrobulbar neuritis, temporal arteritis, 
and ophthalmoplegic migraine. some key points described 
below are recommended to elucidate diagnosis1,4,41 .
clinical presentation of pituitary apoplexy may resem-
ble ruptured intracranial aneurism due to sudden onset 
headache, ocular palsy and altered mental status. Prompt 
diagnosis of pituitary apoplexy is important in patients 
with ocular palsy (ophthalmoplegia is more likely to be 
seen in patients with tumor apoplexy) because decom-
pressive surgery of the optic pathway may alleviate symp-
toms. In patients with aneurismal subarachnoid hemor-
rhage the symptoms develop more rapidly after the onset 
of headache than would be expected in patients with tu-
mor apoplexy5. diagnostic differentiation using only clini-
cal data is not reliable. Frequently time lag between head-
ache and onset of altered mental status is shorter on sub-
arachnoid hemorrhage than on pituitary apoplexy. recur-
rent bleeding may occur not only due to aneurism but pi-
tuitary apoplexy as well.
In the past, cerebrospinal fluid (csF) red cell counting 
took great interest for the differentiation between aneu-
rismatic or pituitary sub-arachnoid hemorrhage. Altered 
mental status together with small red cell counting on 
csF was ordinarily attributed to pituitary apoplexy. high-
er red cell counting however may be seen in pituitary ap-
oplexy especially if there is rupture of diaphragma sell-
ae. currently, csF is used only to detect if there is con-
comitant sub-arachnoid hemorrhage not seen on cT but 
not as a tool for differentiating pituitary apoplexy from 
bleeding aneurisms32. 
treatment
Treatment of pituitary apoplexy in the acute stage is 
still controversial with regard to surgical intervention7,42. 
regardless the severity of clinical presentation the course 
of pituitary apoplexy is unpredictable. The choice for con-
servative or surgical interventions is generally individual-
ly assessed. Untreated patients with apoplexy have high-
er morbidity and mortality. Altered consciousness, hy-
popituitarism, and intercurrent illness account for the in-
creased mortality of untreated patients.
If there is altered mental status without recovery af-
ter neurological and endocrinological treatment surgical 
intervention is required. visual field and visual acuity im-
pairment are also better assessed with surgical decom-
pression after supportive clinical management. Although 
stereotactic aspiration is currently ongoing, open surgery 
via trans-sphenoidal allows a better chance for complete 
tumor removal. The stereotactic method however may be 
required for unstable or high risk patients in spite of open 
surgical access. craniotomy is considered in cases of non-
aired sphenoidal sinus, small sella turcica, great supra-sell-
ar mass, and short diaphragma sellae12,23. 
Thus, trans-sphenoidal via is the procedure of choice 
for bleeding pituitary adenomas. Tumors are generally ne-
crotic or hemorrhagic and easy to aspirate and surgery 
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can be performed without dissection of chiasmatic cis-
terna and lower risk of damaging the superior irrigation 
of optic chiasm. This is relevant since the inferior blood 
supply for optic chiasm is already affected due to adeno-
ma or its expansion due to apoplexy7.
In cases of internal artery carotid compression sur-
gery is urgently required and cannot be postponed un-
less brain infarction is already evident. we believe treat-
ment of pregnant women with pituitary apoplexy should 
be identically managed12. 
ocular palsy has to be evaluated with caution and it 
is recommended that a conservative procedure is better 
than an invasive one in patients with small deficits or with 
recovering symptoms. however early detection of ocu-
lar palsy and severe involvement of extra-ocular muscles 
should be surgically and promptly assessed5. 
As soon as diagnosis of pituitary apoplexy is made 
and after collecting blood sample for hematological, bio-
chemistry, and hormonal analysis, glucocorticoids should 
be administered in supraphysiological doses to serve not 
only as replacement for endogenous hormone deficien-
cy but also to help control the effect of edema. dose rec-
ommended is between 8 to 16 mg dexametasone, or hy-
drocortisone 50 mg intravenously every 6 hours during 
the first 48 hours4,5. occasionally, patients are clinically or 
biochemically hypothyroid at presentation. This aspect of 
endocrine function should be recognized before surgical 
intervention. however, hypothyroidism is not a contrain-
dication for surgery. Unless the hypothyroidism is severe, 
the surgical decompression need not be delayed, but it is 
important to avoid medications and procedures that are 
particularly deleterious and that can potentially worsen 
clinical symptoms, such as depressants and narcotics5.
neurosurgical outcome 
Unless neurosurgery is postponed the results of micro-
surgery decompression after pituitary apoplexy are satis-
factory. The degree of visual field recovery depends much 
on the time for neurosurgery approach than the severity 
of visual deficit. It was seen that surgery within one week 
after pituitary apoplexy lead to a greater visual acuity re-
covery than patients operated later37. The likelihood for 
visual acuity to recover is lower than ocular palsy.
It is important to note that endocrinological follow-
up after surgery is necessary since many patients need 
hormonal replacement for a long-term basis. Patients with 
sub-acute or chronic pituitary apoplexy should have se-
rial (control) neuroimaging and interestingly it is not un-
common to see tumor reduction or even tumor vanishing 
due to apoplexy or necrosis avoiding unnecessary neuro-
surgical removal. 
In conclusion, although pituitary apoplexy is an un-
common complication of pituitary tumors it should be 
recognized as a neuroendocrinological and neurosurgical 
emergence that requires prompt diagnosis and treatment 
individualizing each subject to direct for conservative or 
more invasive therapies. 
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